The Bridge program, which began July 1, makes some Medicare beneficiaries eligible for obesity drugs for $50 a month. CVS and Walgreens say they've each already filled 100,000 such prescriptions.
Many Medicare beneficiaries can now get coverage for obesity drugs such as Wegovy.
Scott Olson/Getty Images
hide caption
toggle caption
Scott Olson/Getty Images
The Medicare GLP-1 Discount Has One Big Catch: Some Sick Patients Don't Qualify - KFF Health News
The Medicare GLP-1 discount is here, so why are some sick people excluded? | Fortune
The Medicare GLP-1 Discount Has One Big Catch: Some Sick Patients Don't Qualify
The program creates the first obesity-only Medicare coverage pathway
The program, which will make weight loss drugs eligible for people on Medicare for $50 a month, is only set to run for 18 months.
Medicare has started covering obesity drugs for the first time – and companies like Walmart and CVS Health are playing an…
The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were…
Older adults on Medicare can get Wegovy and Zepbound for $50 a month, starting in July. But the agency still is not sharing how…
This month, the Centers for Medicare and Medicaid Services launched the Medicare GLP-1 Bridge, a demonstration program that gives…
